[{"Assets_0_Q3_USD":189758000.0,"EarningsPerShareBasic_1_Q3_USD":-1.09,"EarningsPerShareBasic_3_Q3_USD":-3.68,"EarningsPerShareDiluted_1_Q3_USD":-1.09,"EarningsPerShareDiluted_3_Q3_USD":-3.68,"NetIncomeLoss_1_Q3_USD":-58989000.0,"NetIncomeLoss_3_Q3_USD":-189103000.0,"StockholdersEquity_0_Q3_USD":56195000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":54070872.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":51377836.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":54070872.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":51377836.0,"Ticker":"CHRS","CIK":"1512762","name":"COHERUS BIOSCIENCES, INC.","OfficialName":"Coherus BioSciences Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"802681020.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171106"}]